Abstract
Pharmacogenomics, the study of how an individual's genetic makeup influences drug response, is a cornerstone of personalized medicine. By tailoring drug therapies based on genetic profiles, pharmacogenomics aims to optimize efficacy and minimize adverse effects. This article discusses the fundamental concepts of pharmacogenomics, highlights key gene-drug interactions, and explores its applications in clinical settings, including oncology, psychiatry, and cardiology. It also addresses challenges related to implementation, ethical considerations, and future perspectives for integrating pharmacogenomics into routine healthcare.
All articles published in the American Journal of Pharmacy and Pharmacology are licensed under the Creative Commons Attribution 4.0 International License (CC BY 4.0). This license allows others to:
-
Share — copy and redistribute the material in any medium or format
-
Adapt — remix, transform, and build upon the material for any purpose, even commercially
Under the following terms:
-
Attribution — Appropriate credit must be given to the original author(s) and source, a link to the license must be provided, and any changes made must be indicated.
By submitting their work, authors agree to these licensing terms and retain copyright of their articles.